Influence of acute hyperglycemia in human sepsis on inflammatory cytokine and counterregulatory hormone concentrations

被引:91
作者
Yu, WK [1 ]
Li, WQ [1 ]
Li, N [1 ]
Li, LS [1 ]
机构
[1] Nanjing Univ, Coll Med, Res Inst Gen Surg, Jinling Hosp, Nanjing 210002, Jiangsu Prov, Peoples R China
关键词
D O I
10.3748/wjg.v9.i8.1824
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
AIM: In human sepsis, a prominent component of the hypermetabolite is impaired glucose tolerance (IGT) and hyperglycemia. Elevations in plasma glucose concentration impair immune function by altering cytokine production from macrophages. We assessed the role of glucose in the regulation of circulating levels of insulin, glucagon, cortisol, IL-6 and TNF-alpha in human sepsis with normal or impaired glucose tolerance. METHODS: According to the results of intravenous glucose tolerance test, forty patients were classified into two groups: control group (n=20) and IGT group (n=20). Plasma glucose levels were acutely raised in two groups and maintained at 15 mmol/L for 3 hours. Plasma insulin, glucagon and cortisol levels were measured by radioimmunoassay, the levels of TNF-alpha and IL-6 were detected by ELISA. RESULTS: In IGT group, the fasting concentrations of plasma glucose, insulin, glucagon, cortisol, IL-6 and TNF-alpha levels were significantly higher than those in control group (P<0.05). During clamp, the control group had a higher average amount of dextrose infusion than the IGT group (P<0.01). In control group, plasma insulin levels rose from a basal value to a peak at an hour (P<0.05) and maintained at high levels. Plasma glucagon levels descended from a basal value to the lowest level within an hour (P<0.01) and low levels were maintained throughout the clamp. In IGT group, plasma insulin was more significantly elevated (P<0.01), and plasma glucagon levels were not significantly declined. Plasma cortisol levels were not significantly changed in two groups. In control group, plasma IL-6 and TNF-a levels rose (P<0.01) within 2 hours of the clamp and returned to basal values at 3 hours. In IGT group, increased levels of plasma cytokine lasted longer than in control group (3 hours vs. 2 hours, P<0.05), and the cytokine peaks of IGT group were higher (P<0.05) than those of control group. CONCLUSION: Acute hyperglycemia pricks up hyperinsulinemia and increases circulating cytokine concentrations and these effects are more pronounced in sepsis with IGT. This suggests a potential modulation of immunoinflammatory responses in human sepsis by hyperglycemia.
引用
收藏
页码:1824 / 1827
页数:4
相关论文
共 34 条
[1]
Elevated cytosolic calcium and impaired proliferation of B lymphocytes in type II diabetes mellitus [J].
Alexiewicz, JM ;
Kumar, D ;
Smogorzewski, M ;
Massry, SG .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1997, 30 (01) :98-104
[2]
Ascorbate restores endothelium-dependent vasodilation impaired by acute hyperglycemia in humans [J].
Beckman, JA ;
Goldfine, AB ;
Gordon, MB ;
Creager, MA .
CIRCULATION, 2001, 103 (12) :1618-1623
[3]
DEFINITIONS FOR SEPSIS AND ORGAN FAILURE AND GUIDELINES FOR THE USE OF INNOVATIVE THERAPIES IN SEPSIS [J].
BONE, RC ;
BALK, RA ;
CERRA, FB ;
DELLINGER, RP ;
FEIN, AM ;
KNAUS, WA ;
SCHEIN, RMH ;
SIBBALD, WJ .
CHEST, 1992, 101 (06) :1644-1655
[4]
The role of cytokines in the catabolic consequences of infection and injury [J].
Chang, HR ;
Bistrian, B .
JOURNAL OF PARENTERAL AND ENTERAL NUTRITION, 1998, 22 (03) :156-166
[5]
Chen QP, 2001, WORLD J GASTROENTERO, V7, P185
[6]
Glucose-induced release of tumour necrosis factor-alpha from human placental and adipose tissues in gestational diabetes mellitus [J].
Coughlan, MT ;
Oliva, K ;
Georgiou, HM ;
Permezel, JMH ;
Rice, GE .
DIABETIC MEDICINE, 2001, 18 (11) :921-927
[7]
METABOLIC RESPONSE TO SEPSIS AND TRAUMA [J].
DOUGLAS, RG ;
SHAW, JHF .
BRITISH JOURNAL OF SURGERY, 1989, 76 (02) :115-122
[8]
THE GRADING OF SEPSIS [J].
ELEBUTE, EA ;
STONER, HB .
BRITISH JOURNAL OF SURGERY, 1983, 70 (01) :29-31
[9]
Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans - Role of oxidative stress [J].
Esposito, K ;
Nappo, F ;
Marfella, R ;
Giugliano, G ;
Giugliano, F ;
Ciotola, M ;
Quagliaro, L ;
Ceriello, A ;
Giugliano, D .
CIRCULATION, 2002, 106 (16) :2067-2072
[10]
GREGORY R, 1993, FEMS IMMUNOL MED MIC, V7, P315, DOI 10.1111/j.1574-695X.1993.tb00413.x